Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1996 1
1997 1
1998 1
2003 1
2009 3
2010 2
2011 1
2012 1
2014 3
2016 1
2017 2
2018 4
2019 1
2020 3
2021 1
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?
Alongi F, Arcangeli S, Ramella S, Giaj-Levra N, Borghetti P, D'angelillo R, Ricchetti F, Maddalo M, Mazzola R, Trovò M, Russi E, Magrini SM; on the behalf of Associazione Italiana Radioterapia Oncologica (AIRO). Alongi F, et al. Expert Rev Anticancer Ther. 2017 Feb;17(2):157-165. doi: 10.1080/14737140.2017.1273111. Epub 2017 Jan 5. Expert Rev Anticancer Ther. 2017. PMID: 27984919 Review.
Dynomics: A Novel and Promising Approach for Improved Breast Cancer Prognosis Prediction.
Inglese M, Ferrante M, Boccato T, Conti A, Pistolese CA, Buonomo OC, D'Angelillo RM, Toschi N. Inglese M, et al. J Pers Med. 2023 Jun 15;13(6):1004. doi: 10.3390/jpm13061004. J Pers Med. 2023. PMID: 37373993 Free PMC article.
This study leverages a public clinical dataset of dynamic (18)F-Fluorothymidine (FLT) PET scans from BC patients, extending conventional static radiomics methods to the time domain-termed as 'Dynomics'. ...
This study leverages a public clinical dataset of dynamic (18)F-Fluorothymidine (FLT) PET scans from BC patients, extending conventio …
Evidence-based practice among nurses in Italy.
Filippini A, Sessa A, Di Giuseppe G, Angelillo IF. Filippini A, et al. Eval Health Prof. 2011 Sep;34(3):371-82. doi: 10.1177/0163278710387924. Epub 2010 Dec 7. Eval Health Prof. 2011. PMID: 21138912
A cross-sectional survey was conducted among a random sample of 449 nurses in Italy, using a self-administered questionnaire to assess knowledge, attitudes, and behaviors regarding evidence-based practice (EBP). ...While these data were cross-sectional and the response rat …
A cross-sectional survey was conducted among a random sample of 449 nurses in Italy, using a self-administered questionnaire to asses …
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study.
Procopio G, Chiuri VE, Giordano M, Alitto AR, Maisano R, Bordonaro R, Cinieri S, Rossetti S, De Placido S, Airoldi M, Galli L, Gasparro D, Ludovico GM, Guglielmini PF, Carella C, Nova P, Aglietta M, Schips L, Beccaglia P, Sciarra A, Livi L, Santini D; ABItude Study Group. Procopio G, et al. ESMO Open. 2022 Apr;7(2):100431. doi: 10.1016/j.esmoop.2022.100431. Epub 2022 Apr 8. ESMO Open. 2022. PMID: 35405438 Free PMC article.
Diagnostic and Clinical Impact of Staging (18)F-FDG PET/CT in Mantle-Cell Lymphoma: A Two-Center Experience.
Albano D, Ferro P, Bosio G, Fallanca F, Re A, Tucci A, Maria Ferreri AJ, Angelillo P, Gianolli L, Giubbini R, Bertagna F. Albano D, et al. Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e457-e464. doi: 10.1016/j.clml.2019.04.016. Epub 2019 May 3. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31129112
INTRODUCTION: The diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in staging mantle-cell lymphoma has not yet investigated. ...PET/CT permitted upstaging of 21 cases and downstaging of 2. CONCLUSION: …
INTRODUCTION: The diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG P …
Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study.
Ciabattoni A, Gregucci F, D'Ermo G, Dolfi A, Cucciarelli F, Palumbo I, Borghesi S, Gava A, Cesaro GM, Baldissera A, Giammarino D, Daidone A, Maurizi F, Mignogna M, Mazzuoli L, Ravo V, Falivene S, Pedretti S, Ippolito E, Barbarino R, di Cristino D, Fiorentino A, Aristei C, Ramella S, D'Angelillo RM, Meattini I, Iotti C, Donato V, Formenti SC. Ciabattoni A, et al. Cancers (Basel). 2022 Aug 15;14(16):3927. doi: 10.3390/cancers14163927. Cancers (Basel). 2022. PMID: 36010920 Free PMC article.
It focuses on breast cancer (BC) patients treated with radiotherapy (RT) and was developed to create a national registry and define the patterns of care in Italy. A dedicated tool for data collection was created and pilot tested. ...To this aim, Breast IRRADIATA was develo …
It focuses on breast cancer (BC) patients treated with radiotherapy (RT) and was developed to create a national registry and define the patt …
A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis.
Lazzaro C, van Steen C, Ghirelli G, Sacchi M, Sisto D, Uva M, Varano L, Angelillo L. Lazzaro C, et al. Expert Rev Pharmacoecon Outcomes Res. 2023 Feb;23(2):251-265. doi: 10.1080/14737167.2023.2161515. Epub 2023 Jan 9. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 36576091
Latanoprost (+57.60 cost at 2020 values; +0.089 Quality-Adjusted Life Years).The Incremental Cost-Utility Ratio (647.65) falls well below the lower limit of the acceptability range proposed for Italy (25,000-40,000).Sensitivity analyses confirmed the robustness of the base …
Latanoprost (+57.60 cost at 2020 values; +0.089 Quality-Adjusted Life Years).The Incremental Cost-Utility Ratio (647.65) falls well below th …
The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure.
Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Scarselli A, Ferrante P, Bonafede M, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Mazzoleni G, Merler E, Girardi P, Negro C, D'Agostin F, Romanelli A, Chellini E, Silvestri S, Pascucci C, Calisti R, Stracci F, Romeo E, Ascoli V, Trafficante L, Carrozza F, Angelillo IF, Cavone D, Cauzillo G, Tallarigo F, Tumino R, Melis M, Iavicoli S; ReNaM Working Group. Marinaccio A, et al. Occup Environ Med. 2018 Apr;75(4):254-262. doi: 10.1136/oemed-2016-104119. Epub 2017 Dec 21. Occup Environ Med. 2018. PMID: 29269563 Free PMC article.
INTRODUCTION: The epidemiology of gender differences for mesothelioma incidence has been rarely discussed in national case lists. In Italy an epidemiological surveillance system (ReNaM) is working by the means of a national register. ...CONCLUSIONS: The consistent proporti …
INTRODUCTION: The epidemiology of gender differences for mesothelioma incidence has been rarely discussed in national case lists. In Ital …
29 results